Compare
Liquidia vs Merck & (LQDA vs MRK)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Liquidia (LQDA) returned +68.0% and Merck & (MRK) +73.9%; so far this year the figures are +28.7% and +39.4%.
Merck & is the larger company by market value, about 91.1 times the size of Liquidia.
On trailing earnings, LQDA trades at 31.9 times and MRK at 149.7 times.
Revenue grew +2233.6% at LQDA and +4.9% at MRK over the last year.
LQDA pays no dividend. MRK yields 2.32%.
Data as of the latest close. Not investment advice.
Relative performance
| LQDA | MRK | |
|---|---|---|
| Price | $44.40 | $146.73 |
| 1-day | -0.20% | -0.14% |
| YTD | +28.73% | +39.40% |
| 1 year | +68.05% | +73.87% |
| 3 years | +573.75% | +42.66% |
| Market cap | $4.0B | $361.7B |
| P/E | 31.9 | 149.7 |
| P/S | 8.81 | 5.37 |
| P/B | 20.37 | 8.06 |
| Revenue growth | +2233.60% | +4.90% |
| EPS growth | — | -87.10% |
| Gross margin % | 1.8 | 71.8 |
| Net margin % | 30.7 | 3.6 |
| ROE % | 71.0 | 5.5 |
| Debt / equity | 0.10 | 1.20 |
| FCF yield % | 3.8 | 4.1 |
| Dividend yield % | — | 2.32 |
| Beta | 0.91 | 0.18 |
| RSI (14) | 51.0 | 51.3 |
| Technical rating |